Donor site morbidity using the Buccinator Myomucosal Island Flap

Silvano Ferrari, Andrea Ferri, Bernardo Bianchi, Chiara Copelli, Pietro Boni, Enrico Sesenna

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: The objective of this study was to analyze our experience with donor site morbidity after harvesting a buccinator myomucosal island flap (BUMIF) for reconstructing surgical defects involving the tongue and floor of the mouth after oncological resections in 15 consecutive patients. Study design: Donor site morbidity was evaluated using 5 parameters: mouth opening, oral commissure symmetry, inner vestibule restoration, cheek mucosal lining, and the esthetic result. The clinical evaluation was performed by a blinded panel of 2 clinicians and the patient him- or herself, assessing each parameter with a score ranging from 0 to 3. The 3 scores for each parameter were summed to obtain a score reflecting the overall parameter assessment. Results: The mean mouth opening score was 8.6 out of a maximum of 9 (range, 6-9). The mean commissure symmetry was 8.6 (range, 7-9), the mean inferior vestibule score was 8 (range, 6-9), the mean cheek lining score was 8.2 (range, 7-9), and the mean final esthetic score was 8.5 (range, 6-9). Conclusion: The results of this retrospective evaluation demonstrate that when special care is taken in the management of the BUMIF donor site, its morbidity is extremely low, allowing optimal functional and cosmetic results and confirming the major role of this flap in reconstructing moderate-size defects following tongue and floor of the mouth resections.

Original languageEnglish
Pages (from-to)306-311
Number of pages6
JournalOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
Volume111
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Surgical Flaps
Mouth Floor
Cheek
Tissue Donors
Morbidity
Esthetics
Tongue
Mouth
Cosmetics

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery
  • Dentistry(all)
  • Oral Surgery

Cite this

Donor site morbidity using the Buccinator Myomucosal Island Flap. / Ferrari, Silvano; Ferri, Andrea; Bianchi, Bernardo; Copelli, Chiara; Boni, Pietro; Sesenna, Enrico.

In: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, Vol. 111, No. 3, 03.2011, p. 306-311.

Research output: Contribution to journalArticle

Ferrari, Silvano ; Ferri, Andrea ; Bianchi, Bernardo ; Copelli, Chiara ; Boni, Pietro ; Sesenna, Enrico. / Donor site morbidity using the Buccinator Myomucosal Island Flap. In: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2011 ; Vol. 111, No. 3. pp. 306-311.
@article{6a6984212eb140e49d83d8752598483c,
title = "Donor site morbidity using the Buccinator Myomucosal Island Flap",
abstract = "Objective: The objective of this study was to analyze our experience with donor site morbidity after harvesting a buccinator myomucosal island flap (BUMIF) for reconstructing surgical defects involving the tongue and floor of the mouth after oncological resections in 15 consecutive patients. Study design: Donor site morbidity was evaluated using 5 parameters: mouth opening, oral commissure symmetry, inner vestibule restoration, cheek mucosal lining, and the esthetic result. The clinical evaluation was performed by a blinded panel of 2 clinicians and the patient him- or herself, assessing each parameter with a score ranging from 0 to 3. The 3 scores for each parameter were summed to obtain a score reflecting the overall parameter assessment. Results: The mean mouth opening score was 8.6 out of a maximum of 9 (range, 6-9). The mean commissure symmetry was 8.6 (range, 7-9), the mean inferior vestibule score was 8 (range, 6-9), the mean cheek lining score was 8.2 (range, 7-9), and the mean final esthetic score was 8.5 (range, 6-9). Conclusion: The results of this retrospective evaluation demonstrate that when special care is taken in the management of the BUMIF donor site, its morbidity is extremely low, allowing optimal functional and cosmetic results and confirming the major role of this flap in reconstructing moderate-size defects following tongue and floor of the mouth resections.",
author = "Silvano Ferrari and Andrea Ferri and Bernardo Bianchi and Chiara Copelli and Pietro Boni and Enrico Sesenna",
year = "2011",
month = "3",
doi = "10.1016/j.tripleo.2010.05.051",
language = "English",
volume = "111",
pages = "306--311",
journal = "Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics",
issn = "1079-2104",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Donor site morbidity using the Buccinator Myomucosal Island Flap

AU - Ferrari, Silvano

AU - Ferri, Andrea

AU - Bianchi, Bernardo

AU - Copelli, Chiara

AU - Boni, Pietro

AU - Sesenna, Enrico

PY - 2011/3

Y1 - 2011/3

N2 - Objective: The objective of this study was to analyze our experience with donor site morbidity after harvesting a buccinator myomucosal island flap (BUMIF) for reconstructing surgical defects involving the tongue and floor of the mouth after oncological resections in 15 consecutive patients. Study design: Donor site morbidity was evaluated using 5 parameters: mouth opening, oral commissure symmetry, inner vestibule restoration, cheek mucosal lining, and the esthetic result. The clinical evaluation was performed by a blinded panel of 2 clinicians and the patient him- or herself, assessing each parameter with a score ranging from 0 to 3. The 3 scores for each parameter were summed to obtain a score reflecting the overall parameter assessment. Results: The mean mouth opening score was 8.6 out of a maximum of 9 (range, 6-9). The mean commissure symmetry was 8.6 (range, 7-9), the mean inferior vestibule score was 8 (range, 6-9), the mean cheek lining score was 8.2 (range, 7-9), and the mean final esthetic score was 8.5 (range, 6-9). Conclusion: The results of this retrospective evaluation demonstrate that when special care is taken in the management of the BUMIF donor site, its morbidity is extremely low, allowing optimal functional and cosmetic results and confirming the major role of this flap in reconstructing moderate-size defects following tongue and floor of the mouth resections.

AB - Objective: The objective of this study was to analyze our experience with donor site morbidity after harvesting a buccinator myomucosal island flap (BUMIF) for reconstructing surgical defects involving the tongue and floor of the mouth after oncological resections in 15 consecutive patients. Study design: Donor site morbidity was evaluated using 5 parameters: mouth opening, oral commissure symmetry, inner vestibule restoration, cheek mucosal lining, and the esthetic result. The clinical evaluation was performed by a blinded panel of 2 clinicians and the patient him- or herself, assessing each parameter with a score ranging from 0 to 3. The 3 scores for each parameter were summed to obtain a score reflecting the overall parameter assessment. Results: The mean mouth opening score was 8.6 out of a maximum of 9 (range, 6-9). The mean commissure symmetry was 8.6 (range, 7-9), the mean inferior vestibule score was 8 (range, 6-9), the mean cheek lining score was 8.2 (range, 7-9), and the mean final esthetic score was 8.5 (range, 6-9). Conclusion: The results of this retrospective evaluation demonstrate that when special care is taken in the management of the BUMIF donor site, its morbidity is extremely low, allowing optimal functional and cosmetic results and confirming the major role of this flap in reconstructing moderate-size defects following tongue and floor of the mouth resections.

UR - http://www.scopus.com/inward/record.url?scp=79951511434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951511434&partnerID=8YFLogxK

U2 - 10.1016/j.tripleo.2010.05.051

DO - 10.1016/j.tripleo.2010.05.051

M3 - Article

C2 - 20813563

AN - SCOPUS:79951511434

VL - 111

SP - 306

EP - 311

JO - Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

JF - Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

SN - 1079-2104

IS - 3

ER -